Skip to main content
SpringerLink
Log in

Prostacyclin as an endogenous anti-arrhythmic agent

  • Letter to the Editors
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Das, U. N.: Prostaglandins and cardiac arrhythmias. Med. J. Australia2, 44–45 (1981).

    Google Scholar 

  2. Das, U. N.: Prostaglandins and cardiac arrhythmias — a new concept. IRCS Med. Sci.9, 385–387 (1981).

    Google Scholar 

  3. The E.P.S.I.M. Research group: A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. New Engl. J. Med.307, 701–708 (1982).

    Google Scholar 

  4. Das, U. N.: Cardiac pacemaking, cardiac glycosides, anti-arrhythmic drugs and prostaglandins. Speculations. Sci. Tech.2, 381–384 (1979).

    Google Scholar 

  5. Das, U. N.: Possible role of prostaglandins in the pathogenesis of pulmonary hypertension. Prostaglandins Med.4, 163–170 (1980).

    PubMed  Google Scholar 

  6. Moncada, S., R. J. Gryglewski, S. Bunting, J. R. Vane: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature263, 663 (1976).

    PubMed  Google Scholar 

  7. Braunwald, E.: Treatment of the patient after myocardial infarction. The last decade and the next. New Engl. J. Med.302, 290–293 (1980).

    PubMed  Google Scholar 

  8. Coker, S. J., J. R. Parratt, I. McA. Ledingham, I. J. Zeitlin: Thromboxane and prostaglandin release from ischemic myocardium in relation to arrhythmias. Nature291, 323–324 (1981).

    PubMed  Google Scholar 

  9. Au, T. L. S., G. A. Collins, C. J. Harvie, M. J. A. Walker: The actions of prostaglandins I2 and E2 on arrhythmias produced by coronary occlusion in the rat and dog. Prostaglandins18, 707–720 (1979).

    PubMed  Google Scholar 

  10. Karmazyn, M., N. S. Dhalla: A selective concentration dependent dysrhythmogenic and anti-dysrhythmogenic action of prostaglandins E2, F2alpha and I2 on isolated rat hearts. Experientia36, 996 (1980).

    PubMed  Google Scholar 

  11. Das, U. N., M. C. Padma: Role of prostaglandins in bronchial asthma. Med. Hypotheses5, 1317–1321 (1979).

    PubMed  Google Scholar 

  12. Das, U. N.: Prostaglandins in pulmonary hypertension. Int. J. Clin. Pharm. Res.2, 171–174 (1982).

    Google Scholar 

  13. Forster, W.: Prostaglandins, thromboxane A2 and cardiovascular drugs. Pharmazie35, 805 (1980).

    Google Scholar 

  14. Moshos, C. B., B. Haider, A. J. Escobiras, et al.: Chronic use of aspirin versus indomethacin during non-thrombotic myocardial ischemia. Effects on survival. Amer. Heart J.100, 647–652 (1980).

    PubMed  Google Scholar 

  15. Das, U. N., A. M. Lee, G. J. Barritt. Prostanoids can modify response to electrical stimulus and45Ca++ exchange in isolated myocardial cells. Prostaglandins Leukotrienes Med., submitted for publication.

Download references

Author information

Author notes

  1. U. N. Das

    Present address: Department of Genetics, Osmania University, 500 007, Hyderabad, (India)

Authors and Affiliations

    Authors
    1. U. N. Das
      View author publications

      You can also search for this author in PubMed Google Scholar

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    Das, U.N. Prostacyclin as an endogenous anti-arrhythmic agent. Basic Res Cardiol 78, 716–718 (1983). https://doi.org/10.1007/BF01907219

    Download citation

    • Issue Date:

    • DOI: https://doi.org/10.1007/BF01907219

    Keywords

    Search

    Navigation